Skip to content

Analgesia for Positioning Hip Fracture Patients for Spinal Anesthesia

Fascia Iliaca Compartment Block Versus Fentanyl for Positioning Patients With Hip Fractures for Central Nervous Blockade: a Randomized Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02037633
Enrollment
41
Registered
2014-01-16
Start date
2012-07-31
Completion date
2013-02-28
Last updated
2014-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Brief summary

The purpose of this study is to compare two analgesic methods performed preoperatively to assist positioning patients for performance of spinal anesthesia, namely fascia iliaca blockade and intravenous fentanyl.

Interventions

DRUGFentanyl

Fentanyl IV

Fascia iliaca compartment block using ropivacaine

DRUGropivacaine

Sponsors

Asklepieion Voulas General Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Hip fracture

Exclusion criteria

* contraindications for central nervous blockade * impaired cognition or dementia * multiple fractures * any previous analgesic administration during the last 12 hours

Design outcomes

Primary

MeasureTime frame
Pain scores on the Numeric Rating ScaleGroup A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)

Secondary

MeasureTime frameDescription
Duration of spinal anesthesia performanceGroup A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)It will be measured in minutes, from the start of positioning maneuvers to the spinal needle removal
Quality of patient's positionGroup A: 5 minutes after intervention (fentanyl), Group B: 20 minutes after intervention (block)The position will be characterized as unsatisfactory, satisfactory, good or very good

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026